Editor-in-Chief
- Daniel W Chan, Johns Hopkins University
Articles
-
Research
Clinical Proteomics 2013, 10:5 (1 May 2013)Semiquantitative proteomic analysis of human hippocampal tissues from Alzheimer’s disease and age-matched control brains
-
Research
Clinical Proteomics 2013, 10:4 (4 April 2013)Potential tumor biomarkers identified in ovarian cyst fluid by quantitative proteomic analysis, iTRAQ
-
Research
Clinical Proteomics 2013, 10:3 (22 March 2013)Quantitative proteomics for identifying biomarkers for Rabies
-
Research
Clinical Proteomics 2013, 10:2 (8 February 2013)Quantitative proteomic analysis of amniocytes reveals potentially dysregulated molecular networks in Down syndrome
-
Research
Clinical Proteomics 2013, 10:1 (3 January 2013)Proteomic analysis of ERK1/2-mediated human sickle red blood cell membrane protein phosphorylation
- View more articles
In 2011, Clinical Proteomics became a fully open access journal and is now published as part of BioMed Central's portfolio of journals. Clinical Proteomics welcomes new submissions; please check our instructions for authors for details of how to submit.
If you have any questions about the transition of the journal, please email journals@biomedcentral.com.
The journal's back content can be viewed here http://www.springerlink.com/content/120552/.
Aims & scope
Clinical Proteomics encompasses all aspects of translational proteomics. Special emphasis will be placed on the application of proteomic technology to all aspects of clinical research and molecular medicine. The journal is committed to rapid scientific review and timely publication of submitted manuscripts.
Editor's profile
Dr Daniel W Chan is currently Professor of Pathology, Oncology, Urology, and Radiology at Johns Hopkins Medical Institutions, and Director of the Clinical Chemistry Division, Co-Director at the Pathology Core Laboratory, and Director at the Center for Biomarker Discovery at the Johns Hopkins University School of Medicine. He has worked extensively on the development and application of proteomic and immunologic techniques in the understanding of cancer. As the author of five books and over 200 articles, Dr Chan has become established as a leading expert in clinical proteomics and cancer research. Dr. Chan is an active member of Human Proteome Organization (HUPO) and its Plasma Proteome Initiative.
Email updates
Receive periodic news and updates relating to this journal straight to your inbox.
Indexed by
- Embase
- Google Scholar
- OCLC
- PubMed
- Scopus
- Summon by Serial Solutions
